Joinn Laboratories(China)Co (603127.SS) stock: key figures, P/E, revenue and dividend
Health Care · Life Sciences Tools & Services · China · ISIN CNE100002W27
Joinn Laboratories(China)Co financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.02 bn CNY | 1.66 bn CNY |
| Gross profit | 520.82 m CNY | 343.31 m CNY |
| Operating income | 104.35 m CNY | -42.12 m CNY |
| EBIT | 83.69 m CNY | 338.91 m CNY |
| Net income | 74.08 m CNY | 297.84 m CNY |
| Diluted EPS – continuing operations | 0.10 CNY | 0.40 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Joinn Laboratories(China)Co
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.
More stocks
- OUTFRONT Media Inc. (OUT)
- CG Oncology, Inc. (CGON)
- Glarun Technology Co Ltd (600562.SS)
- JBT MAREL Corp (JBTM)
- Tokyu Fudosan Holdings Corp (3289.T)
- RadNet, Inc. (RDNT)
- Logista Integral SA (LOG.MC)
- BALCHEM CORP (BCPC)
- Mobility Global Inc. (MBGL)
- APT Medical Inc (688617.SS)
- Atlantic Union Bankshares Corp (AUB)
- Shanghai Wanye Enterprises Co Ltd (600641.SS)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.